| [1] |
Steiner PE, Luschbaugh CC. Landmark article, Oct. 1941: Maternal pulmonary embolism byamniotic fluid as a cause of obstetric shock and unexpected deaths in obstetrics. By Paul E. Steiner and C. C. Lushbaugh[J]. JAMA, 1986, 255(16):2187-2203.
|
| [2] |
Clark SL, Hankins GD, Dudley DA, et al. Amniotic fluid embolism: analysis of the national registry[J]. Am J Obstet Gynecol, 1995, 172(4 Pt 1):1158-1167.
|
| [3] |
Clark SL. Amniotic fluid embolism[J]. Obstet Gynecol, 2014, 123 (2 Pt 1):337-348.
|
| [4] |
Rath WH, Hoferr S, Sinicina I. Amniotic fluid embolism: an interdisciplinary challenge: epidemiology, diagnosis and treatment[J]. Dtsch Arztebl Int, 2014, 111(8):126-132.
|
| [5] |
Busardo FP, Frati P, Karch SB, et al. Epidemiological and clinical data of amniotic fluid embolism in forensic settings[J]. Curr Pharm Biotechnol, 2014, 14(14):1189-1194.
|
| [6] |
周远洋，朱军，王艳萍，等. 1996－2010年全国孕产妇死亡率变化趋势[J]. 中华预防医学杂志，2011, 45(10):934-939.
|
| [7] |
Stolk KH, Zwart JJ, Schutte J, et al. Severe maternal morbidity and mortality from amniotic fluid embolism in the Netherlands[J]. Acta Obstet Gyncol Scand, 2012, 91(8):991-995.
|
| [8] |
Roberts CL, Algert CS, Knight M, et al. Amniotic fluid embolism in an Australian population-based cohort[J]. BJOG, 2010, 117(11):1417-1421.
|
| [9] |
Stolte L, van Kessel H, Seelen J, et al. Failure to produce the syndrome of amniotic fluid embolism by infusion of amniotic fluid and meconium into monkeys[J]. Am J Obstet Gynecol, 1967, 98(5):694-697.
|
| [10] |
Clark SL, Pavlova Z, Horenstein J, et al. Squamous cells in the maternal pulmonary circulation[J]. Am J Obstet Gynecol, 1986, 154(1):104-106.
|
| [11] |
Benson MD, Lindberg RE. Amniotic fluid embolism, anaphylaxis, and tryptase[J]. Am J Obstet Gynecol, 1996, 175 (3 Pt 1):737.
|
| [12] |
Marcu BJ, Collins KA, Harley RA. Ancillary studies in amniotic fluid embolism: a case report and review of the literature[J]. Am J Forensic Med Pathol, 2005, 26(1): 92-95.
|
| [13] |
Benson MD. Current concepts of immunology and diagnosis in amniotic fluid embolism[J]. Clin Dev Immunol, 2012, 2012:946576.
|
| [14] |
Benson MD, Kobayashi H, Sehgal RL, et al. Complement, fetal antigen and shaking rigors in parturients[J]. J Matern Fetal Neonatal Med, 2006, 19(1):31-34.
|
| [15] |
Benson MD. A hypothesis regarding complement activation and amniotic fluid embolism[J]. Medical Hypotheses, 2007, 68(5):1019-1025.
|
| [16] |
Romero R, Kadar N, Vaisbuch E, et al. Maternal death following cardiopulmonary collapse after delivery: amniotic fluid embolism or septic shock due to intrauterine infection？[J]. Am J Reprod Immunol, 2010, 64(2):113-125.
|
| [17] |
Uszyński W, ？ekanowska E, Uszyński M, et al. Activation contact system (ACS) and tissue factor (TF) in human amniotic fluid: measurements of ACS components and TF, and some implications on the pathophysiology of amniotic fluid embolism[J]. Thromb Res, 2015, 135(4):699-702.
|
| [18] |
池小玲，孙静莉. 羊水栓塞发病机制的免疫学研究进展[J]. 中华临床医师杂志(电子版), 2013, 7(9):4003-4005.
|
| [19] |
Rannou B, Rivard GE, Gains MJ, et al. Intravenous injection of autologous amniotic fluid induces transient thrombocytopenia in a gravid rabbit model of amniotic fluid embolism[J]. Vet Clin Pathol, 2011, 40(4):524-529.
|
| [20] |
Chen KB, Chang SS, Tseng YL, et al. Amniotic fluid induces platelet-neutrophil aggregation and neutrophil activation[J]. Am J Obstet Gynecol, 2013, 208(4):318.e1-318.e7.
|
| [21] |
Abenhaim HA, Azoulay L, Kramer MS, et al. Incidence and risk factors of amniotic fluid embolisms: a population-based study on 3 million births in the United States[J]. Am J Obstet Gynecol, 2008, 199(1):49.e1-49.e8.
|
| [22] |
Kramer MS, Rouleau J, Baskett TF, et al. Amniotic-fluid embolism and medical induction of labour: a retrospective, population-based cohort study[J]. Lancet, 2006, 368(9545):1444-1448.
|
| [23] |
Knight M, Tuffnell D, Brocklehurst P, et al. Incidence and risk factors for amniotic-fluid embolism[J]. Obstet Gynecol, 2010, 115(5):910-917.
|
| [24] |
Kramer MS, Rouleau J, Liu S, et al. Maternal Health Study Group of the Canadian Perinatal Surveillance System. Amniotic fluid embolsim: incidence, risk factors, and impact on perinatal outcome[J]. BJOG, 2012, 119(7):874-879.
|
| [25] |
Spiliopoulos M, Puri I, Jain NJ, et al. Amniotic fluid embolism-risk factors, maternal and neonatal outcomes[J]. J Matern Fetal Neonatal Med, 2009, 22(5):439-444.
|
| [26] |
Turillazzi E, Neri M, Bello S, et al. Amniotic fluid embolism: moving diagnosis through the time. From the mechanical pulmonary vascular occlusion until an immuno-inflammatory pathogenesis？[J]. Curr Pharm Biotechnol, 2014, 14(14):1179-1188.
|
| [27] |
Stawicki SP, Papadimos TJ. Challenges in managing amniotic fluid embolism: an up-to-date perspective on diagnostic testing with focus on novel biomarkers and avenues for future research[J]. Curr Pharm Biotechnol, 2014, 14(14):1168-1178.
|
| [28] |
Knight M, Tuffnell D, Brocklehurst P, et al. Incidence and risk factors for amniotic-fluid embolism[J]. Obstet Gynecol, 2010, 115(5):910-917.
|
| [29] |
McDonnell NJ, Percival V, Paech MJ. Amniotic fluid embolism: a leading cause of maternal death yet still a medical conundrum[J]. Int J Obstet Anesth, 2013, 22(4):329-336.
|
| [30] |
Kanayama N, Tamura N. Amniotic fluid embolism: pathophysiology and new strategies for management[J]. J Obstet Gynaecol Res, 2014, 40(6):1507-1517.
|
| [31] |
Cunningham FG, Leveno KJ, Bloom SL, et al. Williams Obstetrics[M]. 24th ed. New York: McGraw-Hill Professional, 2014：813.
|
| [32] |
Conde-Agudelo A, Romero R. Amniotic fluid embolism: an evidence-based review[J]. Am J Obstet Gynecol, 2009, 201(5):445.e1-445.e13.
|
| [33] |
Frati P, Foldes-Papp Z, Zaami S, et al. Amniotic fluid embolism: what level of scientific evidence can be drawn? A systematic review[J]. Curr Pharm Biotechnol, 2014, 14(14):1157-1162.
|
| [34] |
Leighton BL, Wall MH, Lockhart EM, et al. Use of recombinant factor VIIa in patients with amniotic fluid embolism: a systematic review of case reports[J]. Anesthesiology, 2011, 115(6):1201-1208.
|